METHYLDOPA tablet Spojené státy - angličtina - NLM (National Library of Medicine)

methyldopa tablet

cardinal health - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 250 mg

METHYLDOPA tablet film coated Spojené státy - angličtina - NLM (National Library of Medicine)

methyldopa tablet film coated

teva pharmaceuticals usa inc - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 250 mg

METHYLDOPA tablet, film coated Spojené státy - angličtina - NLM (National Library of Medicine)

methyldopa tablet, film coated

rebel distributors corp - methyldopa (unii: 56lh93261y) (methyldopa - unii:56lh93261y) - hypertension. methyldopa is contraindicated in patients: - with active hepatic disease, such as acute hepatitis and active cirrhosis. - with liver disorders previously associated with methyldopa therapy (see warnings ). - with hypersensitivity to any component of this product. - on therapy with monoamine oxidase (mao) inhibitors.

METHYLDOPA MYLAN methyldopa (as sesquihydrate) 250 mg tablet bottle Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

methyldopa mylan methyldopa (as sesquihydrate) 250 mg tablet bottle

alphapharm pty ltd - methyldopa sesquihydrate -

Methyldopa Viatris Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

methyldopa viatris

viatris limited - methyldopa sesquihydrate 283mg equivalent to to 250 mg methyldopa anhydrous;   - tablet - 250 mg - active: methyldopa sesquihydrate 283mg equivalent to to 250 mg methyldopa anhydrous   excipient: citric acid   colloidal silicon dioxide disodium edetate dihydrate ethylcellulose guar gum magnesium stearate opadry yellow oy-8462 purified water sodium starch glycolate - hypertension (mild, moderate or severe).

Prodopa Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

prodopa

viatris limited - methyldopa sesquihydrate 141.5mg equivalent to to 125 mg methyldopa anhydrous - tablet - 125 mg - active: methyldopa sesquihydrate 141.5mg equivalent to to 125 mg methyldopa anhydrous excipient: citric acid   colloidal silicon dioxide disodium edetate dihydrate ethylcellulose guar gum magnesium stearate opadry yellow oy-8462 purified water sodium starch glycolate - hypertension (mild, moderate or severe).

METHYLDOPATE HYDROCHLORIDE injection solution Spojené státy - angličtina - NLM (National Library of Medicine)

methyldopate hydrochloride injection solution

american regent, inc. - methyldopate hydrochloride (unii: 7px435dn5a) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopate hydrochloride 50 mg in 1 ml

Methyldopa Remedica 250 mg film-coated tablets Malajsie - angličtina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

methyldopa remedica 250 mg film-coated tablets

eucogen sdn bhd - methyldopa -

METHYLDOPA tablet, film coated Spojené státy - angličtina - NLM (National Library of Medicine)

methyldopa tablet, film coated

chartwell rx, llc - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa is contraindicated in patients: — with active hepatic disease, such as acute hepatitis and active cirrhosis — with liver disorders previously associated with methyldopa therapy ( see warnings ) — with hypersensitivity to any component of these products. — on therapy with monoamine oxidase (mao) inhibitors.

Methyldopa 250mg tablets Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

methyldopa 250mg tablets

ennogen pharma ltd - methyldopa (anhydrous) - oral tablet - 250mg